Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.61M Buy
+51,433
New +$6.02M 0.13% 199
2025
Q3
Sell
-111,815
Closed -$8.85M 1861
2025
Q2
$8.85M Buy
+111,815
New +$8.89M 0.22% 89
2024
Q2
Sell
-17,066
Closed -$2.25M 1727
2024
Q1
$2.25M Sell
17,066
-99,648
-85% -$12.3M 0.17% 145
2023
Q4
$12.7M Buy
+116,714
New +$12.1M 1.18% 1
2023
Q2
Sell
-17,171
Closed -$1.83M 1554
2023
Q1
$1.83M Buy
+17,171
New +$1.85M 0.21% 111
2022
Q4
Sell
-4,209
Closed -$362K 1223
2022
Q3
$362K Buy
+4,209
New +$376K 0.04% 643
2022
Q2
Sell
-31,411
Closed -$2.58M 1073
2022
Q1
$2.58M Buy
31,411
+28,446
+959% +$2.24M 0.59% 17
2021
Q4
$227K Buy
+2,965
New +$236K 0.05% 479
2021
Q3
Sell
-5,042
Closed -$392K 818
2021
Q2
$392K Buy
+5,042
New +$375K 0.1% 330
2021
Q1
Sell
-9,597
Closed -$738K 728
2020
Q4
$738K Buy
+9,597
New +$734K 0.31% 79

Other funds holding MRK

Y-Intercept (HK)'s MRK Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Merck (MRK) in Q2 2026: 51,433 shares worth $6.61M. The stake represents 0.13% of the portfolio and ranks #199 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in MRK as recently as Q2 2025.

Y-Intercept (HK) first reported a position in MRK in Q4 2020 and has held it in 10 quarters since. The position peaked at $12.7M in Q4 2023. 954 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Y-Intercept (HK) held 51,433 shares of Merck worth $6.61M as of Q2 2026.
  • Merck was a new Y-Intercept (HK) position in Q2 2026.
  • Merck made up 0.13% of Y-Intercept (HK)'s portfolio in Q2 2026, its #199 holding.
  • Y-Intercept (HK) first reported a position in Merck in Q4 2020 and has held it in 10 quarters since.
  • Y-Intercept (HK)'s Merck position peaked at $12.7M in Q4 2023.
  • 954 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.